glp-1 drugs market dynamics 2025 Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Receptor Agonist Market Size
Description
Your outcome will reflect your specific conditions
PMCID: PMC4215190
Your energy goes up
22,23 Obese HFpEF patients have greater LV hypertrophy and pulmonary capillary wedge pressure, increased LV filling pressures and severe right ventricular dysfunction compared with non-obese HFpEF patients
M., Iqbal, N., et al
